1. Journal Articles7

Showing results 1 to 7 of 7

  • Qian, Yu ; 
  • Panaampon, Jutatip ; 
  • Chapuy, Bjoern ; 
  • Zhang, Xueyan ; 
  • Zhao, Xiujuan ; 
  • Wang, Zhe ; 
  • Zhang, Pengfei ; 
  • Payungwong, Tongchai ; 
  • Zhang, Aretina ; 
  • Ke, Qiang ; 
  • et al
  • 2026-07
  • CELL REPORTS, v.45, no.7
  • CELL PRESS
  • View : 81
  • Download : 0
  • Kim, Sojeong ; 
  • Kwak, Jeong-Eun ; 
  • Koh, June-Young ; 
  • Lee, Ji Eun ; 
  • Kook, Hye Won ; 
  • Kim, Minchae ; 
  • Chung, Haerim ; 
  • Kim, Yuri ; 
  • Kim, Soo Jeoong ; 
  • Kim, Jin Seok ; 
  • et al
  • 2025-07
  • Blood, v.146, no.4, pp.456 - 470
  • American Society of Hematology
  • View : 237
  • Download : 0
  • 2025-11
  • Applied Spectroscopy Reviews, v.60, no.9-10, pp.832 - 868
  • Taylor & Francis
  • View : 448
  • Download : 0
  • Noh, Soojeong ; 
  • Ryu, Suyeon ; 
  • Jung, Dokyung ; 
  • Shin, Sanghee ; 
  • Jung, Inseong ; 
  • Kang, Sung-Min ; 
  • Kim, Christine S. ; 
  • Choi, Sung-Jin ; 
  • Cho, Hanchae ; 
  • Schwämmle, Melanie ; 
  • et al
  • 2024-12
  • Noh, Soojeong. (2024-12). IL2-mediated modulation of small extracellular vesicles secretion and PD-L1 expression: a novel perspective for neutralizing immune suppression within cancer cells. Cancer Communications, 44(12), 1422–1426. doi: 10.1002/cac2.12623
  • Wiley
  • View : 338
  • Download : 0
  • Jeong, Seongmin ; 
  • Jang, Nawon ; 
  • Kim, Minchae ; 
  • Choi, Il-Kyu
  • 2023-02
  • Jeong, Seongmin. (2023-02). CD4+ cytotoxic T cells: an emerging effector arm of anti-tumor immunity. BMB Reports, 56(3), 140–144. doi: 10.5483/BMBRep.2023-0014
  • 생화학분자생물학회
  • View : 575
  • Download : 0
  • Zhang, Baochun ; 
  • Choi, Il-Kyu ; 
  • Panaampon, Jutatip ; 
  • Wang, Zhe
  • 2022-12
  • Zhang, Baochun. (2022-12). Does delayed EBV infection contribute to rising childhood cancers? Trends in Immunology, 43(12), 956–958. doi: 10.1016/j.it.2022.09.009
  • Elsevier Ltd
  • View : 424
  • Download : 0
  • 2022-10
  • Zhang, Baochun. (2022-10). Facts and Hopes in the Relationship of EBV with Cancer Immunity and Immunotherapy. Clinical Cancer Research, 28(20), 4363–4369. doi: 10.1158/1078-0432.CCR-21-3408
  • American Association for Cancer Research
  • View : 482
  • Download : 0
1

Recent Submissions